腹腔镜“淋巴引流区”清扫联合胃局部切除术治疗早期胃癌的再认识

定期复查胃镜，早期发现早期治疗 #生活知识# #科技生活# #健康生活技巧# #胃癌#

摘要:

前哨淋巴结的检查和活检对于及时诊断和治疗肿瘤非常重要。临床上针对早期胃癌常采用内镜黏膜下剥离术等技术，但存在无法精确直观地判断有无淋巴结转移导致错失治疗时机等风险。胃恶性肿瘤中存在包含着前哨淋巴结的“淋巴引流区”，腹腔镜下对“淋巴引流区”进行清扫可以获取前哨淋巴结，并通过对清扫获得的前哨淋巴结进行活检来指导手术。由此“淋巴引流区”清扫联合胃局部切除术不仅能够达到内镜黏膜下剥离术的治疗效果，同时又能避免遗漏肿瘤淋巴结微转移的风险，是一种值得推荐的手术方式。本文针对此术式的相关难点及问题进行综述，以供临床借鉴参考。

Abstract:

Sentinel node (SN) detection and biopsy are important for timely diagnosis and treatment of cancer. Endoscopic submucosal dissection technique is clinically used to treat early gastric cancer, but there is not accurate intuitive judgment of lymph metastasis so as to increase the risk of missing the timing of treatment. Malignant gastric tumor contains lymphatic basin with the sentinel lymph node. Sentinel lymph node can be obtained to guide the surgery by lymphatic basin dissection. So, laparoscopic local gastrectomy combined with lymphatic basin dissection is a recommendable operation, and it can not only achieve the therapeutic effect of endoscopic submucosal dissection but also avoid the risk of lymph node micrometastasis. In this paper, the related difficulties and problems of this technology are summarized for clinical reference.

[1]

Fukunaga T, Hiki N, Kubota T, et al. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer[J]. Ann Surg Oncol, 2013, 20(8): 2676-82. doi: 10.1245/s10434-013-2930-9

[2]

Katai H, Sasako M, Fukuda H, et al. Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage Ⅰ gastric cancer: a multicenter phase Ⅱ trial (JCOG 0703)[J]. Gastric Cancer, 2010, 13(4): 238-44. doi: 10.1007/s10120-010-0565-0

[3]

Inaki N, Etoh T, Ohyama T, et al. A Multi-institutional, Prospective, Phase Ⅱ Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901)[J]. World J Surg, 2015, 39(11): 2734-41. doi: 10.1007/s00268-015-3160-z

[4]

Nakada K, Ikeda M, Takahashi M, et al. Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients[J]. Gastric Cancer, 2015, 18(1): 147-58. doi: 10.1007/s10120-014-0344-4

[5]

Nakada K, Takahashi M, Ikeda M, et al. Factors affecting the quality of life of patients after gastrectomy as assessed using the newly developed PGSAS-45 scale: A nationwide multi-institutional study[J]. World J Gastroenterol, 2016, 22(40): 8978-90. doi: 10.3748/wjg.v22.i40.8978

[6]

Takiguchi N, Takahashi M, Ikeda M, et al. Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study[J]. Gastric Cancer, 2015, 18(2): 407-16. doi: 10.1007/s10120-014-0377-8

[7]

Terashima M, Tanabe K, Yoshida M, et al. Postgastrectomy Syndrome Assessment Scale (PGSAS)-45 and changes in body weight are useful tools for evaluation of reconstruction methods following distal gastrectomy[J]. Ann Surg Oncol, 2014, 21(Suppl 3): S370-8. doi: 10.1245/s10434-014-3583-z

[8]

Songun I, Putter H, Kranenbarg E, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial[J]. Lancet Oncol, 2010, 11(5): 439-49. doi: 10.1016/S1470-2045(10)70070-X

[9]

Degiuli M, Sasako M, Ponti A, et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer[J]. Br J Surg, 2014, 101(2): 23-31. doi: 10.1002/bjs.9345

[10]

Fujita J, Takahashi M, Urushihara T, et al. Assessment of postoperative quality of life following pylorus-preserving gastrectomy and Billroth-Ⅰ distal gastrectomy in gastric cancer patients: results of the nationwide postgastrectomy syndrome assessment study[J]. Gastric Cancer, 2016, 19(1): 302-11. doi: 10.1007/s10120-015-0460-9

[11]

Fujimura T, Fushida S, Kayahara M, et al. Transectional gastrectomy: an old but renewed concept for early gastric cancer[J]. Surg Today, 2010, 40(5): 398-403. doi: 10.1007/s00595-009-4151-1

[12]

Kinami S, Funaki H, Fujita H, et al. Local resection of the stomach for gastric cancer[J]. Surg Today, 2017, 47(6): 651-9. doi: 10.1007/s00595-016-1371-z

[13]

Namikawa T, Hiki N, Kinami S, et al. Factors that minimize postgastrectomy symptoms following pylorus-preserving gastrectomy: assessment using a newly developed scale (PGSAS-45)[J]. Gastric Cancer, 2015, 18(2):397-406. doi: 10.1007/s10120-014-0366-y

[14]

Koeda K, Chiba T, Noda H, et al. Intracorporeal reconstruction after laparoscopic pylorus-preserving gastrectomy for middle-third early gastric cancer: a hybrid technique using linear stapler and manual suturing[J]. Langenbecks Arch Surg, 2016, 401(3): 397-402. doi: 10.1007/s00423-016-1378-3

[15]

Muraoka A, Kobayashi M, Kokudo Y. Laparoscopy-Assisted Proximal Gastrectomy with the Hinged Double Flap Method[J]. World J Surg, 2016, 40(10): 2419-24. doi: 10.1007/s00268-016-3510-5

[16]

Kinami S, Fujimura T, Ojima E, et al. PTD classification: proposal for a new classification of gastric cancer location based on physiological lymphatic flow[J]. Int J Clin Oncol, 2008, 13(4): 320-9. doi: 10.1007/s10147-007-0755-x

[17]

Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma[J]. Arch Surg, 1992, 127(4): 392-9. doi: 10.1001/archsurg.1992.01420040034005

[18]

Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer[J]. J Clin Oncol, 2000, 18(13): 2553-9. doi: 10.1200/JCO.2000.18.13.2553

[19]

Kitagawa Y, Fujii H, Mukai M, et al. Radio-guided sentinel node detection for gastric cancer[J]. Br J Surg, 2002, 89(5): 604-8. doi: 10.1046/j.1365-2168.2002.02065.x

[20]

Miyashiro I, Hiratsuka M, Sasako M, et al. High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302[J]. Gastric Cancer, 2014, 17(2): 316-23. doi: 10.1007/s10120-013-0285-3

[21]

Kitagawa Y, Takeuchi H, Takagi Y, et al. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan[J]. J Clin Oncol, 2013, 31(29): 3704-10. doi: 10.1200/JCO.2013.50.3789

[22]

Kinami S, Oonishi T, Fujita J, et al. Optimal settings and accuracy of indocyanine green fluorescence imaging for sentinel node biopsy in early gastric cancer[J]. Oncol Lett, 2016, 11(6): 4055-62. doi: 10.3892/ol.2016.4492

[23]

Wang Z, Dong ZY, Chen JQ, et al. Diagnostic value of sentinel lymph node biopsy in gastric cancer: a meta-analysis[J]. Ann Surg Oncol, 2012, 19(5): 1541-50. doi: 10.1245/s10434-011-2124-2

[24]

Takeuchi H, Ueda M, Oyama T, et al. Molecular diagnosis and translymphatic chemotherapy targeting sentinel lymph nodes of patients with early gastrointestinal cancers[J]. Digestion, 2010, 82(3):187-91. doi: 10.1159/000309464

[25]

Yaguchi Y, Sugasawa H, Tsujimoto H, et al. One-step nucleic acid amplification (OSNA) for the application of sentinel node concept in gastric cancer[J]. Ann Surg Oncol, 2011, 18(8): 2289-96. doi: 10.1245/s10434-011-1591-9

[26]

Kusano M, Tajima Y, Yamazaki K, et al. Sentinel node mapping guided by indocyanine green fluorescence imaging: a new method for sentinel node navigation surgery in gastrointestinal cancer[J]. Dig Surg, 2008, 25(2):103-8. doi: 10.1159/000121905

[27]

Tajima Y, Yamazaki K, Masuda Y, et al. Sentinel node mapping guided by indocyanine green fluorescence imaging in gastric cancer[J]. Ann Surg, 2009, 249(1): 58-62. doi: 10.1097/SLA.0b013e3181927267

[28]

Toyota T, Fujito H, Suganami A, et al. Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives[J]. Bioorg Med Chem, 2014, 22(2): 721-7. doi: 10.1016/j.bmc.2013.12.026

[29]

Brouwer OR, Buckle T, Vermeeren L, et al. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT[J]. J Nucl Med, 2012, 53(7): 1034-40. doi: 10.2967/jnumed.112.103127

[30]

Symeonidis D, Koukoulis G, Tepetes K. Sentinel node navigation surgery in gastric cancer: Current status[J]. World J Gastrointest Surg, 2014, 6(6): 88-93. doi: 10.4240/wjgs.v6.i6.88

[31]

Kiyozaki H, Saito M, Chiba H, et al. Laparoscopic wedge resection of the stomach for gastrointestinal stromal tumor (GIST): non-touch lesion lifting method[J]. Gastric Cancer, 2014, 17(2): 337-40. doi: 10.1007/s10120-013-0272-8

网址：腹腔镜“淋巴引流区”清扫联合胃局部切除术治疗早期胃癌的再认识 https://www.yuejiaxmz.com/news/view/797133

相关内容

胃癌手术原则与术后注意事项
幽门螺杆菌阳性=胃癌？除这4类人群外都建议治疗！
做了颈部淋巴清扫后一年了还疼什么原因
间歇性雄激素全阻断疗法联合手术去势用于局部进展期前列腺癌的临床疗效及对生活质量的影响
胃癌根治术的饮食禁忌有哪些
高盐饮食+幽门螺杆菌=胃癌高危 就着葱蒜来吃饭可防胃癌吗
与胃有关的这些误区该澄清了
肛管癌的主要治疗方案
肺腺癌淋巴结没有清扫可以第二次手术清扫么？
守胃健康，胃癌预防小知识学起来

随便看看